Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genome engineering with type I CRISPR systems in eukaryotic cells

Genome engineering with type I CRISPR systems in eukaryotic cells

US Patent 11421251 · Granted Aug 23, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Genome engineering with CRISPR-Cas systems in eukaryotes2025
Genome engineering with CRISPR-Cas systems in eukaryotes2025
CRISPR/Cas9-based repressors for silencing gene targets in vivo and methods of u2025
Therapeutic targets for the correction of the human dystrophin gene by gene edit2025
Therapeutic applications of CPF1-based genome editing2025
Compositions and methods for the induction and tuning of gene expression2025
Compositions and methods for epigenome editing2025
Genetic correction of mutated genes2024
Genome engineering with Type I CRISPR systems in eukaryotic cells2024
Genome engineering with Type I CRISPR systems in eukaryotic cells2024
Genome engineering with Type I CRISPR systems in eukaryotic cells2024
Methods and compositions for RNA-directed repression of transcription using CRIS2022